Talcum Powder Lawsuits
If you or a loved one have been diagnosed with ovarian cancer or fallopian tube cancer and have used Johnson & Johnson’s Baby Powder, Shower to Shower powder, or WalMart’s Equate powder as part of your feminine hygiene routine, you may be entitled to compensation. Free Consultation. No money out of pocket to file your claim.
TALCUM POWDER LAWSUIT UPDATE
Since the early 1970’s, numerous studies have indicated an increased risk of ovarian cancer in women who use products containing talc around their genital area. Talcum powder has the ability to absorb moisture, reduce friction, and have an astringent effect on human skin, properties that make talc a popular ingredient in cosmetics and hygiene products.
Over the years, numerous studies have emerged that link talc with an increased risk in ovarian cancer:
- A 1971 study examined the ovaries of numerous women who had been diagnosed with ovarian cancer and found the presence of talc particles in the ovarian tissue of those samples.
- In 1982, Cancer, a medical journal, published a study that concluded that women who used talcum powder on sanitary napkins in their vaginal area were 33% more likely to develop ovarian cancer.
- A 2003 study analyzed data collected in a number of previous studies on this topic and concluded that using talc products in the vaginal area resulted in a one-third increase in ovarian cancer risks.
- A 2013 study published in Cancer Prevention Research suggested that women who use talcum powder in the genital area are at an increased risk of developing ovarian cancer. In that particular study, the data on 2,000 women showed that those who used talc body powder in their genital areas may have a 20 to 30 percent higher risk of developing ovarian cancer than those who do not.
JOHNSON & JOHNSON FOUND GUILTY OF NEGLIGENCE
In February 2016, a St. Louis jury found Johnson & Johnson responsible for ovarian cancer that caused the death of Jackie Fox, a woman who had used Johnson’s baby powder for years. It is the first case in which a jury ordered Johnson & Johnson to pay damages for negligence in not warning consumers about the correlation between their talc products and ovarian cancer, despite decades of knowledge of this correlation.
The jury foreman, Krista Smith, cited Johnson & Johnson’s internal company documents as the clear decisive reason for the judgment. Said Smith, “It was really clear they were hiding something. All they had to do was put a label on it.”
“It was really clear they were hiding something. All they had to do was put a label on it.”
In another claim filed in South Dakota against Johnson & Johnson, Deane Berg stated she had used Johnson & Johnson’s Baby Powder and Shower-to-Shower as part of her daily hygiene routine for over 30 years. She claimed the usage of these products caused her to develop ovarian cancer. As proof of this, samples of cancerous tissues taken from Berg were examined by three doctors, all of whom found talc particles within the tissue and concluded the cancer was caused by the talcum powder.
Daniel Cramer, one of the three doctors, testified that in his thirty years of studying the link between talcum powder and ovarian cancer he concluded that talcum powder was a factor in 10,000 ovarian cases annually.
The Jury in Berg’s case decided that Johnson & Johnson was negligent not to warn consumers about the dangers associated with their talcum powder products.
Since this decision, additional lawsuits have been filed against Johnson & Johnson. In April of 2014 Mona Estrada filed a complaint in California alleging that while Johnson & Johnson is aware of the risks related to the usage of their talcum powder products, they have made no efforts to warn consumers about these risks. Estrada’s complaint alleges that the author of a 1982 study linking talcum powder to ovarian cancer advised a doctor employed by Johnson & Johnson to put a warning label about the risk of ovarian cancer on their talcum powder products.
DO I HAVE A CASE?
Sanders Phillips Grossman is currently accepting cases from women across the United States and Puerto Rico who have been harmed by the use of talcum powder products. If you or a loved one have been diagnosed with ovarian cancer or fallopian tube cancer and have used Johnson & Johnson Baby Powder, Shower to Shower powder, or WalMart’s Equate powder products containing talc, you may be eligible for compensation. A successful outcome on your claim could entitle you to damages for medical expenses, wage loss, pain and suffering, loss of enjoyment of life, and loss of consortium.
Unfortunately, we are currently unable to pursue claims for cervical cancer, vaginal cancer, vulvar cancer, endometrial cancer, borderline tumors, ovarian cysts, and non-malignant tumors.
WHAT WILL AN ATTORNEY COST ME?
We represent our clients on a contingency fee basis. This means that you pay no attorney fees until we win your claim. If we are unable to successfully resolve your claim, you are not obligated to pay attorneys’ fees.
ABOUT SANDERS PHILLIPS GROSSMAN
Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.
Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.
Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.
Read more about our attorneys here.